4//SEC Filing
Duarte Ira 4
Accession 0000950170-25-013044
CIK 0000818033other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 12:44 PM ET
Size
7.6 KB
Accession
0000950170-25-013044
Insider Transaction Report
Form 4
Duarte Ira
EVP, Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-01-31+374,220→ 374,220 totalExercise: $1.70Exp: 2035-01-31→ Common Stock (374,220 underlying) - Award
Restricted Stock Units
2025-01-31+187,110→ 187,110 totalExercise: $0.00→ Common Stock (187,110 underlying)
Footnotes (2)
- [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (January 31, 2025).
- [F2]The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).
Documents
Issuer
HERON THERAPEUTICS, INC. /DE/
CIK 0000818033
Entity typeother
Related Parties
1- filerCIK 0001488864
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 12:44 PM ET
- Size
- 7.6 KB